We are a small, focused team developing peptide and fusion-protein therapeutics for type 2 diabetes, obesity and NASH.
No specific vacancies are posted at present. Speculative applications are welcome and are reviewed as roles open.
Discovery through candidate selection: computational design, structure-based analysis, non-clinical pharmacology, formulation and CMC — across four platforms rather than a single asset.
Scientists and engineers in peptide chemistry, protein engineering, pharmacology, DMPK and CMC who want depth in one therapeutic area rather than breadth.
Send a CV and a short note on what you would want to work on to info@finnegens.com. Applications are read by the team.